Publication | Closed Access

A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial

OncologyGastrointestinal OncologyClinical TrialsPathologyColorectal CancerMetastatic Colorectal CancerPharmacotherapyCancer TreatmentMedicineRadiation OncologyHealth Sciences